Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 7 de 7
Filtrar
Más filtros












Intervalo de año de publicación
1.
Exp Eye Res ; 246: 109992, 2024 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-38972445

RESUMEN

Previous studies have shown that pharmaceutical agents such as lipoic acid have the ability to soften the lens, presenting a promising avenue for treating presbyopia. One obstacle encountered in the preclinical stage of such agents is the need for precise measurements of lens elasticity in experimental models. This study aimed to evaluate the effects of 25-hydroxycholesterol, lipoic acid, and obeticholic acid on the viscoelastic properties of mouse lenses using a custom-built elastometer system. Data were acquired on lenses from C57BL/6J female mice from two age groups: young (age: 8-10 weeks) and old (age: 32-43 weeks). OD lenses were used as the control and OS lenses were treated. Control lenses were immersed in Dulbecco's Modified Eagle Medium (DMEM) and treatment lenses were immersed in a compound solution containing 25-hydroxycholesterol (5 young and 5 old), lipoic acid at 2.35 mM (5 young and 5 old), lipoic acid at 0.66 mM (5 old), or obeticholic acid (5 old) at 37 °C for 18 h. After treatment, the mouse lenses were placed in a DMEM-filled chamber within a custom-built elastometer system that recorded the load and lens shape as the lens was compressed by 600 µm at a speed of 50 µm/s. The load was continuously recorded during compression and during stress-relaxation. The compression phase was fit with a linear function to quantify lens stiffness. The stress-relaxation phase was fit with a 3-term exponential relaxation model providing relaxation time constants (t1, t2, t3), and equilibrium load. The lens stiffness, time constants and equilibrium load were compared for the control and treated groups. Results revealed an increase in stiffness with age for the control group (young: 1.16 ± 0.11 g/mm, old: 1.29 ± 0.14 g/mm) and relaxation time constants decreased with age (young: t1 = 221.9 ± 29.0 s, t2 = 24.7 ± 3.8 s, t3 = 3.12 ± 0.87 s, old: t1 = 183.0 ± 22.0 s, t2 = 20.6 ± 2.6 s and t3 = 2.24 ± 0.43 s). Among the compounds tested, only 25-hydroxycholesterol produced statistically significant changes in the lens stiffness, relaxation time constants, and equilibrium load. In conclusion, older mouse lenses are stiffer and less viscous than young mouse lenses. Notably, no significant change in lens stiffness was observed following treatment with lipoic acid, contrary to previous findings.


Asunto(s)
Ácido Quenodesoxicólico , Elasticidad , Cristalino , Ratones Endogámicos C57BL , Ácido Tióctico , Animales , Ratones , Cristalino/efectos de los fármacos , Femenino , Ácido Tióctico/farmacología , Ácido Tióctico/análogos & derivados , Ácido Quenodesoxicólico/análogos & derivados , Ácido Quenodesoxicólico/farmacología , Viscosidad , Envejecimiento/fisiología , Antioxidantes/farmacología , Hidroxicolesteroles/farmacología
2.
Anal Methods ; 16(22): 3486-3491, 2024 Jun 06.
Artículo en Inglés | MEDLINE | ID: mdl-38804096

RESUMEN

To thoroughly understand ferroptosis's biological functions in living cells, it is crucial to investigate the polarity variations that occur during this unique Fe(II)-facilitated oxidative type of cell death. In this work, we report the development of a ratiometric probe (Po-P) to visualize the polarity changes in living cells and the inhibition effect during ferroptosis. The polarity-responsive fluorophore utilized by Po-P has a D-π-A-type structure. Based on theoretical calculations, ICT was proposed as the basis for Po-P's polarity-responsive mechanism. According to cell imaging results, Po-P had a desirable capacity for monitoring polarity fluctuations and erastin-induced ferroptosis. Furthermore, inhibition imaging revealed that dihydrolipoic acid (DHLA) could potentially prevent polarity changes that occur during erastin-induced ferroptosis, just as vitamin E (VE). We anticipate that the probe Po-P could be a valuable tool to quickly monitor polarity fluctuations and inhibition effects during ferroptosis and create new medications for treating disorders related to ferroptosis.


Asunto(s)
Ferroptosis , Colorantes Fluorescentes , Ferroptosis/efectos de los fármacos , Colorantes Fluorescentes/química , Colorantes Fluorescentes/farmacología , Humanos , Ácido Tióctico/farmacología , Ácido Tióctico/química , Ácido Tióctico/análogos & derivados , Imagen Óptica/métodos , Piperazinas/farmacología , Piperazinas/química
3.
ACS Infect Dis ; 10(6): 2172-2182, 2024 Jun 14.
Artículo en Inglés | MEDLINE | ID: mdl-38724014

RESUMEN

Lipoic acid (LA) is an essential cofactor in prokaryotic and eukaryotic organisms, required for the function of several multienzyme complexes such as oxoacid dehydrogenases. Prokaryotes either synthesize LA or salvage it from the environment. The salvage pathway in Staphylococcus aureus includes two lipoate-protein ligases, LplA1 and LplA2, as well as the amidotransferase LipL. In this study, we intended to hijack the salvage pathway by LA analogues that are transferred via LplA2 and LipL to the E2 subunits of various dehydrogenases, thereby resulting in nonfunctional enzymes that eventually impair viability of the bacterium. Initially, a virtual screening campaign was carried out to identify potential LA analogues that bind to LplA2. Three selected compounds affected S. aureus USA300 growth in minimal medium at concentrations ranging from 2.5 to 10 µg/mL. Further analysis of the most potent compound (Lpl-004) revealed its transfer to E2 subunits of dehydrogenase complexes and a negative impact on its functionality. Growth impairment caused by Lpl-004 treatment was restored by adding products of the lipoate-dependent enzyme complexes. In addition, Caenorhabditis elegans infected with LpL-004-treated USA300 demonstrated a significantly expanded lifespan compared to worms infected with untreated bacteria. Our results provide evidence that LA analogues exploiting the LA salvage pathway represent an innovative strategy for the development of novel antimicrobial substances.


Asunto(s)
Antibacterianos , Staphylococcus aureus , Ácido Tióctico , Ácido Tióctico/farmacología , Ácido Tióctico/análogos & derivados , Staphylococcus aureus/efectos de los fármacos , Staphylococcus aureus/enzimología , Staphylococcus aureus/genética , Virulencia , Animales , Antibacterianos/farmacología , Antibacterianos/química , Péptido Sintasas/metabolismo , Péptido Sintasas/genética , Caenorhabditis elegans , Proteínas Bacterianas/metabolismo , Proteínas Bacterianas/genética , Infecciones Estafilocócicas/microbiología , Infecciones Estafilocócicas/tratamiento farmacológico
4.
Anal Chem ; 96(17): 6652-6658, 2024 04 30.
Artículo en Inglés | MEDLINE | ID: mdl-38630909

RESUMEN

A low-triggering potential and a narrow-potential window are anticipated to decrease the electrochemical interference and cross talk of electrochemiluminescence (ECL). Herein, by exploiting the low oxidative potential (0.82 V vs Ag/AgCl) of dihydrolipoic acid-capped sliver nanoclusters (DHLA-AgNCs), a coreactant ECL system of DHLA-AgNCs/hydrazine (N2H4) is proposed to achieve efficient and oxidative-reduction ECL with a low-triggering potential of 0.82 V (vs Ag/AgCl) and a narrow-potential window of 0.22 V. The low-triggering-potential and narrow-potential-window nature of ECL can be primarily preserved upon labeling DHLA-AgNCs to probe DNA and immobilizing DHLA-AgNCs onto the Au surface via sandwiched hybridization, which eventually enables a selective ECL strategy for the gene assay at +0.82 V. This gene assay strategy can sensitively determine the gene of human papillomavirus from 10 to 1000 pM with a low limit of detection of 5 pM (S/N = 3) and would open a way to improve the applied ECL bioassay.


Asunto(s)
Técnicas Electroquímicas , Mediciones Luminiscentes , Nanopartículas del Metal , Plata , Ácido Tióctico/análogos & derivados , Plata/química , Técnicas Electroquímicas/métodos , Nanopartículas del Metal/química , Mediciones Luminiscentes/métodos , Humanos , Ácido Tióctico/química , Técnicas Biosensibles/métodos , ADN Viral/análisis , ADN Viral/genética , Límite de Detección
5.
Aging (Albany NY) ; 16(3): 2679-2701, 2024 02 01.
Artículo en Inglés | MEDLINE | ID: mdl-38305803

RESUMEN

Renal cell carcinoma (RCC) is the predominant form of malignant kidney cancer. Sunitinib, a primary treatment for advanced, inoperable, recurrent, or metastatic RCC, has shown effectiveness in some patients but is increasingly limited by drug resistance. Recently identified cuproptosis, a copper-ion-dependent form of programmed cell death, holds promise in combating cancer, particularly drug-resistant types. However, its effectiveness in treating drug resistant RCC remains to be determined. Exploring cuproptosis's regulatory mechanisms could enhance RCC treatment strategies. Our analysis of data from the GEO and TCGA databases showed that the cuproptosis-related gene DBT is markedly under expressed in RCC tissues, correlating with worse prognosis and disease progression. In our study, we investigated copper CRGs in ccRCC, noting substantial expression differences, particularly in advanced-stage tumors. We established a connection between CRG expression levels and patient survival, positioning CRGs as potential therapeutic targets for ccRCC. In drug resistant RCC cases, we found distinct expression patterns for DBT and GLS CRGs, linked to treatment resistance. Our experiments demonstrated that increasing DBT expression significantly reduces RCC cell growth and spread, underscoring its potential as a therapeutic target. This research sheds new light on the role of CRGs in ccRCC and their impact on drug resistance.


Asunto(s)
Carcinoma de Células Renales , Neoplasias Renales , Ácido Tióctico/análogos & derivados , Humanos , Carcinoma de Células Renales/tratamiento farmacológico , Carcinoma de Células Renales/genética , Sunitinib/farmacología , Sunitinib/uso terapéutico , Cobre , Neoplasias Renales/tratamiento farmacológico , Neoplasias Renales/genética , Apoptosis
6.
Acta cir. bras ; 29(supl.1): 12-18, 2014. tab, graf
Artículo en Inglés | LILACS | ID: lil-720407

RESUMEN

PURPOSE: To evaluate the tissue response of the mucosa of the tympanic cavity of guinea pigs, when receiving biodegradable implant. METHODS: A total of 20 male guinea pigs were divided into 2 groups. After paracentesis in both ears, a biodegradable polymer of poly lactic-co-glycolic acid was implanted in only one middle ear. Histological analysis using neutrophil exudate and vascular neoformation (acute inflammation) and fibroblast proliferation and mononuclear inflammatory cells (chronic inflammation) as parameters was performed after 10 and 30 days of survival (groups 1 and 2, respectively). RESULTS: Four ears in group 1 and 7 in group 2 had an increase of neutrophil exudate. Vascular neoformation occurred in ears with or without the implant, in both groups. Fibroblast proliferation and mononuclear inflammatory cells (lymphocytes and macrophages) increased in ears with implant in group 2. CONCLUSION: The tissue response by histological analysis of the mucosa of the tympanic cavity of guinea pigs, when receiving biodegradable implant, showed no statistically significant difference between ears with or without the implant. .


Asunto(s)
Animales , Cobayas , Masculino , Implantes Absorbibles , Oído Medio/efectos de los fármacos , Lactatos/uso terapéutico , Polímeros/uso terapéutico , Ácido Tióctico/análogos & derivados , Biopolímeros/uso terapéutico , Exudados y Transudados , Oído Medio/patología , Fibroblastos/efectos de los fármacos , Membrana Mucosa/efectos de los fármacos , Membrana Mucosa/patología , Neovascularización Patológica , Neutrófilos/efectos de los fármacos , Distribución Aleatoria , Reproducibilidad de los Resultados , Factores de Tiempo , Ácido Tióctico/uso terapéutico
7.
Rev. argent. microbiol ; 32(3): 136-143, jul.-sept. 2000.
Artículo en Inglés | LILACS | ID: lil-332524

RESUMEN

Dihydrolipoamide dehydrogenase (LADH) from Trypanosoma cruzi, the causative agent of Chagas' disease, was inactivated by treatment with myeloperoxidase (MPO)-dependent systems. LADH lipoamide reductase and diaphorase activities decreased as a function of incubation time and composition of the MPO/H2O2/halide system, a transient increase preceding the loss of diaphorase activity. Iodide, bromide, thiocyanide and chloride were effective components of MPO/H2O2 or MPO/NADH systems. Catalase prevented LADH inactivation by the MPO/NADH/halide systems in agreement with H2O2 production by NADH-supplemented LADH. Thiol compounds (L-cysteine, N-acetylcysteine, penicillamine, N-(2-mercaptopropionylglycine) and Captopril prevented LADH inactivation by the MPO/H2O2/NaCl system and by NaOCl, thus supporting HOCl as agent of the MPO/H2O2/NaCl system. MPO/H2O2/NaNO2 and MPO/NADH/NaNO2 inactivated LADH, the reaction being prevented by MPO inhibitors and thiol compounds. T. cruzi LADH was affected by MPO-dependent systems like myocardial LADH, allowance being made for the variation of the diaphorase activity and the greater sensitivity of the T. cruzi enzyme to MPO/H2O2/halide systems.


Asunto(s)
Animales , Humanos , Ácido Hipocloroso/farmacología , Dihidrolipoamida Deshidrogenasa , Neutrófilos/fisiología , Nitritos , Peroxidasa , Proteínas Protozoarias/antagonistas & inhibidores , Estallido Respiratorio , Trypanosoma cruzi , Acetilcisteína/farmacología , Ácido Tióctico/análogos & derivados , Ácido Tióctico/metabolismo , Bromuros , Captopril , Catalasa , Cisteína/farmacología , Cloruro de Sodio/farmacología , Compuestos de Sodio/farmacología , Citotoxicidad Inmunológica , Especies Reactivas de Oxígeno/metabolismo , Glutatión , Glicina , Cinética , Miocardio , NAD , Neutrófilos/enzimología , Oxidación-Reducción , Penicilamina , Peróxido de Hidrógeno/farmacología , Proteínas Recombinantes/antagonistas & inhibidores , Compuestos de Sulfhidrilo , Triptófano , Tirosina
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...